Evogene Ltd. (TLV:EVGN)
Israel flag Israel · Delayed Price · Currency is ILS · Price in ILA
264.20
+7.90 (3.08%)
At close: Mar 13, 2026

Evogene Ratios and Metrics

Millions ILS. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
23264715292221
Market Cap Growth
-33.78%-44.67%-68.75%64.52%-58.37%-59.72%
Enterprise Value
27353780-964
Last Close Price
2.643.017.2729.9822.3553.75
PS Ratio
1.882.131.537.4615.6476.49
PB Ratio
0.600.690.881.470.751.12
P/TBV Ratio
----1.901.85
EV/Sales Ratio
2.212.851.213.96-22.04
Debt / Equity Ratio
0.180.180.170.040.050.04
Net Debt / Equity Ratio
-0.90-0.90-0.86-1.04-0.96-0.81
Net Debt / EBITDA Ratio
0.840.840.631.211.381.78
Net Debt / FCF Ratio
0.790.790.631.341.352.00
Asset Turnover
0.130.130.190.110.030.01
Inventory Turnover
4.044.042.835.272.76-
Quick Ratio
4.314.310.904.576.418.00
Current Ratio
4.544.541.164.966.718.27
Return on Equity (ROE)
-100.69%-100.69%-82.96%-81.78%-60.78%-50.61%
Return on Assets (ROA)
-29.28%-29.28%-30.52%-30.90%-25.43%-26.10%
Return on Capital Employed (ROCE)
-84.50%-84.50%-104.90%-60.00%-53.30%-44.60%
Earnings Yield
-117.44%-103.24%-126.79%-56.75%-101.68%-39.07%
FCF Yield
-188.75%-165.92%-156.34%-53.14%-94.85%-35.94%
Buyback Yield / Dilution
-38.21%-38.21%-24.14%-10.80%-2.44%-43.59%
Source: S&P Global Market Intelligence. Standard template. Financial Sources.